VAERS reports by lot

Moderna COVID-19 lot A57140C: VAERS reports

22 VAERS reports list lot A57140C as a Moderna COVID-19 vaccine, received between 2022-09-27 and 2023-05-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
18%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3136%
Gastrointestinal1315%
Neurological1214%
Cardiac / Cardiovascular1011%
Respiratory89%
Musculoskeletal56%
Thrombotic / Hematological33%
Dermatological (non-injection-site)22%
Autoimmune / Immune-mediated11%
Allergic / Anaphylactic11%
Injection-site / Local reaction11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts5
California3
Arizona2
Iowa2
North Carolina1
Connecticut1
New Jersey1
Minnesota1
Michigan1
Utah1
Florida1
Ohio1

Reports by month received

2022-091
2022-107
2022-112
2022-122
2023-021
2023-037
2023-041
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.